The Neurodegenerative Diseases Drugs Market represents a critical segment of the pharmaceutical industry, dedicated to developing therapies for conditions characterized by progressive degeneration of nerve cells. Disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS) fall within this domain, profoundly affecting patient quality...